Old Web
English
Sign In
Acemap
>
authorDetail
>
Hao Wu
Hao Wu
Shenyang Pharmaceutical University
Pharmacology
Anticoagulant
Thrombus
Medicine
Fibrinolysis
5
Papers
39
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety assessment of Aconitum-Derived bulleyaconitine A: A 91-day oral toxicity study and a tissue accumulation study in rats
2021
Traditional Chinese Medicine
Shi-liang Yin
Feng Xu
Hao Wu
Fei Li
Ge Jin
Zu-Qian Wu
Ran Meng
Si-Man Ma
Fan Zhou
Peter Breslin
Chunfu Wu
Hong Zhang
Show All
Source
Cite
Save
Citations (0)
Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress.
2020
Redox biology
Hao Wu
Ying Wang
Yupeng Zhang
Feng Xu
Jiepeng Chen
Lili Duan
Tingting Zhang
Jian Wang
Fengjiao Zhang
Show All
Source
Cite
Save
Citations (28)
Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.
2019
Glycoconjugate Journal
Hao Wu
Huan Wang
Wei Li
Chi Zhang
Yushan Liu
Feng Xu
Jiepeng Chen
Lili Duan
Fengjiao Zhang
Show All
Source
Cite
Save
Citations (0)
Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.
2019
Glycoconjugate Journal
Hao Wu
Huan Wang
Wei Li
Chi Zhang
Yushan Liu
Feng Xu
Jiepeng Chen
Lili Duan
Fengjiao Zhang
Show All
Source
Cite
Save
Citations (2)
Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention
2019
Regulatory Toxicology and Pharmacology
Hao Wu
Huan Wang
Feng Xu
Jiepeng Chen
Lili Duan
Fengjiao Zhang
Show All
Source
Cite
Save
Citations (9)
1